New
ICON
The AI engine Fit Assessment
BetaICON develops digital solutions and operates within the pharmaceutical industry, providing a range of services to support drug development.
Blurb
ICON is a global provider of outsourced drug development services to biopharma, medical device, biosimilar and generic organizations.
HQ Location
Dublin (Ireland)
Founded
1990
Employees
+10000
Total funding raised
$2.00B
Funding Status
Post-IPO Debt, $2.00B, April 30, 2024
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies.